glp 1 medications for obesity GLP-1 Weight Loss Explained: Who Should Consider Them and Why Who should actually take a
Description
A new 68-week trial found that weekly injections with CagriSema resulted in greater weight loss (up to 14.2%) compared with 10.2% for semaglutide (Wegovy)
[Google Scholar] 3.Kim W, Egan JM The role of incretins in glucose homeostasis and diabetes treatment
How quickly you see results depends on how you are checking for those results and factors including how resistant you are to weight loss
Importantly, patient education should not be overlooked
Published December 11, 2025
& Franks, N
